Published November 12, 2004 | Version v1
Journal article

The C-terminal peptide of thrombospondin-4 stimulates erythroid cell proliferation

  • 1. Endocrine Laboratory, McGill University Health Centre, Montreal (Canada)
  • 2. McGill University and Genome Quebec Innovation Centre, Montreal (Canada)
  • 3. MDS-Pharma Services, Montreal (Canada)

Description

Erythropoietin (EPO) stimulates the production of small erythroid cell stimulating factors (molecular weight <5 kDa) in cultures of bone marrow endothelial cells. We identified a fragment of thrombospondin-4 (TSP-4) as an EPO-stimulated protein in endothelial cell lysates. Pre-incubation of the low molecular weight fractions from supernatants of EPO-treated umbilical cord endothelial cells (HUVEC) with antibodies against the C-terminal residues of TSP-1,2 and TSP-4 decreased the erythroid cell stimulating activity. The C-terminal TSP-1 section corresponding to a molecular weight lower than 6 kDa has the integrin-associated protein binding motif VVM. The corresponding TSP-4 fragment, lacking the three residue sequence VVM, has a distinctive acidic peptide comprising the last 21 amino acids (C21) with the characteristics of an amphipathic helix. C21 stimulated thymidine incorporation into bovine erythroid cells, increased cell numbers in cultures of cord blood CD36+ erythroid precursors and skin fibroblasts, and decreased HUVEC proliferation. SC21, a homologous peptide of identical amino acid composition but with interchanged residues, was non-amphipathic and had no erythroid cell stimulating activity

Additional details

Identifiers

DOI
10.1016/j.bbrc.2004.09.107;
PII
S0006-291X(04)02160-6;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
324
Journal Issue
2
Journal Page Range
p. 673-678
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.